NO20055582L - Preparater og fremgangsmater omfattende gastrinforbindelser - Google Patents

Preparater og fremgangsmater omfattende gastrinforbindelser

Info

Publication number
NO20055582L
NO20055582L NO20055582A NO20055582A NO20055582L NO 20055582 L NO20055582 L NO 20055582L NO 20055582 A NO20055582 A NO 20055582A NO 20055582 A NO20055582 A NO 20055582A NO 20055582 L NO20055582 L NO 20055582L
Authority
NO
Norway
Prior art keywords
compositions
methods
gastrin compounds
beneficial effects
gastrin
Prior art date
Application number
NO20055582A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055582D0 (no
Inventor
Antonio Cruz
Original Assignee
Waratah Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/016660 external-priority patent/WO2003100024A2/en
Application filed by Waratah Pharmaceuticals Inc filed Critical Waratah Pharmaceuticals Inc
Publication of NO20055582D0 publication Critical patent/NO20055582D0/no
Publication of NO20055582L publication Critical patent/NO20055582L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20055582A 2003-05-27 2005-11-25 Preparater og fremgangsmater omfattende gastrinforbindelser NO20055582L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2003/016660 WO2003100024A2 (en) 2002-05-24 2003-05-27 Treatment for diabetes
PCT/CA2004/000769 WO2004105780A2 (en) 2003-05-27 2004-05-27 Compositions comprising gastrin compounds and their use in diabetes

Publications (2)

Publication Number Publication Date
NO20055582D0 NO20055582D0 (no) 2005-11-25
NO20055582L true NO20055582L (no) 2006-02-27

Family

ID=33488788

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055582A NO20055582L (no) 2003-05-27 2005-11-25 Preparater og fremgangsmater omfattende gastrinforbindelser

Country Status (11)

Country Link
EP (1) EP1648495A2 (https=)
JP (1) JP2007513059A (https=)
CN (1) CN1829528A (https=)
AU (1) AU2004243541A1 (https=)
BR (1) BRPI0410710A (https=)
CA (1) CA2527186A1 (https=)
MX (1) MXPA05012605A (https=)
NO (1) NO20055582L (https=)
PL (1) PL379145A1 (https=)
RU (1) RU2005140518A (https=)
WO (1) WO2004105780A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL156828A0 (en) 2001-01-12 2004-02-08 Waratah Pharmaceuticals Inc Prolonged efficacy of islet neogenesis therapy methods with a gastrin/cck receptor ligand and an egf receptor ligand composition in subjects with preexisting diabetes
EP1837031B1 (en) 2002-06-07 2009-10-14 Waratah Pharmaceuticals, Inc. Compositions and methods for treating diabetes
US7560425B2 (en) 2002-06-07 2009-07-14 Waratah Pharmaceuticals Inc. Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes
US20090202494A1 (en) * 2004-01-30 2009-08-13 Antonio Cruz Combined use of glp-1 agonists and gastrin for regulating blood glucose levels
WO2008106779A1 (en) * 2007-03-02 2008-09-12 Waratah Pharmaceuticals Inc. Gastrin compound for diabetes treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
DE69431212T2 (de) * 1994-01-24 2003-04-10 The General Hospital Corp., Boston Behandlung von diabetes
IL156828A0 (en) * 2001-01-12 2004-02-08 Waratah Pharmaceuticals Inc Prolonged efficacy of islet neogenesis therapy methods with a gastrin/cck receptor ligand and an egf receptor ligand composition in subjects with preexisting diabetes
KR20050074492A (ko) * 2002-10-22 2005-07-18 와라타 파마수티컬즈, 인크. 당뇨병의 치료

Also Published As

Publication number Publication date
EP1648495A2 (en) 2006-04-26
RU2005140518A (ru) 2007-07-10
BRPI0410710A (pt) 2006-06-13
WO2004105780A2 (en) 2004-12-09
AU2004243541A1 (en) 2004-12-09
CN1829528A (zh) 2006-09-06
CA2527186A1 (en) 2004-12-09
JP2007513059A (ja) 2007-05-24
PL379145A1 (pl) 2006-07-24
MXPA05012605A (es) 2006-02-22
NO20055582D0 (no) 2005-11-25
WO2004105780A3 (en) 2005-01-20

Similar Documents

Publication Publication Date Title
NO20091976L (no) Nye forbindelser
ATE484508T1 (de) Furylverbindungen
IS7721A (is) Píperidín-pýrídasón og þalasón sem PDE4 hemlar
MX2007005933A (es) Compuestos de acetamida como fungicidas.
NO20070608L (no) Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast
MX2007005408A (es) Compuestos de aminoquinazolinas.
IS2696B (is) Setin 2-amínótetralín fyrir meðhöndlunina á geðdeyfð
ATE477256T1 (de) Thienylverbindungen
MX2007005932A (es) 1-alquinil-2-ariloxialquilamidas y su uso como fungicidas.
MXPA05011962A (es) Oxiarenos substituidos.
IN2012DN02609A (https=)
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
TW200600499A (en) Novel amido-substituted hydroxy-6-phenylphenanthridines
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
MXPA06004308A (es) Isopentilcarboxanilidas para la lucha contra los microorganismos indeseables.
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
IL189286A0 (en) Novel cysteine protease inhibitors and their therapeutic applications
NO20055582L (no) Preparater og fremgangsmater omfattende gastrinforbindelser
MXPA06000372A (es) Compuestos de silicio y su uso.
MX2007002917A (es) Todo-trans-retinol: todo-trans-13, 14-dihidrorretinol saturasa y metodos de uso de la misma.
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
TW200609226A (en) New isobenzoxazinones and their use as ultraviolet light absorbers
DK1638948T3 (da) Diphenylurinstofderivater og deres anvendelse som chloridkanalblokkere
NO20071330L (no) Enzyminhibitor i leukemi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application